CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: EVOLVE Short DAPT Study [Phase 4]
Summary
Phase 4 clinical trial update for the EVOLVE Short DAPT study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-09-25